Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
December 2, 2016
At a recent Pfizer/ Cytel seminar on rare disease and oncology development, Cytel’s Lingyun Liu presented innovative...
Read article
October 5, 2015
2 Methods for Evaluating Biomarker Subpopulations | Cytel
One consideration every sponsor of a biomarker-stratified confirmatory trial must take into account, is whether to...
Read article
November 4, 2014
New Exploratory Trial Method Translates into Better Financial Strategy
A key stage of exploratory drug development is implementing a proof-of-concept study to demonstrate the safety of a...
Read article
September 18, 2014
5 times ‘Keep it Simple’ May Be Bad Advice for Clinical Designers
When designing clinical trials, many trial designers are advised to keep the trial simple. Prima facie, the keep it...
Read article
July 10, 2014
Designs for Biomarker Driven Population Enrichment in Oncology
Complexities with identifying suitable test populations in oncology studies contribute significantly to the 60%...
Read article